Inventor · disambiguated record
Kalet León Monzón
Also filed as: LEON MONZON KALET · LEÓN MONZÓN KALET
6 granted patents·10 pending applications·97 citations·filing 2010–2023
77Inventor score
Files withCT INMUNOLOGIA MOLECULAR8CENTRO DE IMMUNOLOGIA MOLECULAR2LEÓN MONZÓN KALET2BIOCON LTD1CENTRO DE INMUMOLOGIA MOLECULAR1
Top patents by PatentIndex Score
16 records- 0188US9206243B2IL-2 derivative polypeptidesLEÓN MONZÓN KALET·Filed 2011·Granted Dec 8, 2015·64 cites·33 claims
- 0284US8759486B2Immunomodulatory interleukin-2 polypeptides and methods of treating melanomaLEÓN MONZÓN KALET·Filed 2010·Granted Jun 24, 2014·33 cites·13 claims
- 0359US2025179139A1Human interleukin-2-derived muteins with superagonist activityCT INMUNOLOGIA MOLECULAR·Filed 2023·Application pending·0 cites
- 0451US2024279348A1Use of monoclonal antibodies against the epidermal growth factor receptor in the treatment of patients with hypoxemic acute respiratory failureCT INMUNOLOGIA MOLECULAR·Filed 2022·Application pending·0 cites
- 0549US2023151107A1Anti-cd6 antibody compositions and methods for treating and reducing negative effects of a coronavirus including covid-19BIOCON LTD·Filed 2021·Application pending·0 cites
- 0649US2025049890A1Fusion proteins composed of an antibody and a muteinCT INMUNOLOGIA MOLECULAR·Filed 2022·Application pending·0 cites
- 0748US11926654B2Fusion proteins composed of an interleukin-2 mutein and type I interferonCT INMUNOLOGIA MOLECULAR·Filed 2019·Granted Mar 12, 2024·0 cites·17 claims
- 0848US2024042013A1Use of vaccine compositions based on sars-cov-2 receptor binding domain in delivering protective immunityINST FINLAY DE VACUNAS·Filed 2021·Application pending·0 cites
- 0947US2023256069A1Use of epidermal growth factor depleting agents in the treatment of chronic obstructive pulmonary diseaseCT INMUNOLOGIA MOLECULAR·Filed 2021·Application pending·0 cites
- 1047US2024173392A1Use of therapeutic compositions for the treatment of patients with tumors of epithelial originCENTRO DE INMUNOLGGIA MOLECULAR·Filed 2022·Application pending·0 cites
- 1143US2023226163A1Inorganic nanoparticle-based vaccine compositions for cancer treatmentCT INMUNOLOGIA MOLECULAR·Filed 2021·Application pending·0 cites
- 1243US2023018364A1Stable high-concentration forumulation of nimotuzumab antibodyCENTRO DE IMMUNOLOGIA MOLECULAR·Filed 2020·Application pending·0 cites
- 1341US2022152107A1Method for expansion and differentiation of t lymphocytes and nk cells for adoptive transfer therapiesCT INMUNOLOGIA MOLECULAR·Filed 2020·Application pending·0 cites
- 1440US9701730B2TGFβ-derived polypeptides and uses thereofCT INMUNOLOGIA MOLECULAR·Filed 2013·Granted Jul 11, 2017·0 cites·14 claims
- 1539US11718676B2Antibodies with increased affinity for the epidermal growth factor receptor and fragments derived therefromCENTRO DE INMUMOLOGIA MOLECULAR·Filed 2018·Granted Aug 8, 2023·0 cites·11 claims
- 1630US9790279B2Pharmaceutical compositions for the treatment of tumors expressing EGFR and GM3 N-glycolyl ganglioside (NeuGcGM3)CENTRO DE IMMUNOLOGIA MOLECULAR·Filed 2012·Granted Oct 17, 2017·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Kalet León Monzón files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →